Housing for surgical sealant applicator system
Latest Bristol-Myers Squibb Company Patents:
- Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors
- Antibodies Binding to Human PAD4 and Uses Thereof
- Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment
- Substituted bicyclic compounds useful as T cell activators
- METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
Description
FIG. 1 is a perspective view of a front and a right side of a housing for surgical sealant applicator system showing my new design;
FIG. 2 is a perspective view of a front thereof;
FIG. 3 is a rear perspective view thereof;
FIG. 4 is a perspective view of a right side thereof, the left side being a mirror image thereof; and,
FIG. 5 is a top perspective view thereof, shown at an enlarged scale.
The bottom is plain and unornamented.
The elements shown in phantom lines do not form any part of the design of the present application.
Claims
The ornamental design for a housing for surgical sealant applicator system, as shown and described.
Referenced Cited
Patent History
Patent number: D438302
Type: Grant
Filed: Aug 25, 1999
Date of Patent: Feb 27, 2001
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventor: Steve McGugan (Copenhagen)
Primary Examiner: Alan P. Douglas
Assistant Examiner: Reid Hecker
Attorney, Agent or Law Firms: Theodore R. Furman, Jr., Stuart E. Krieger
Application Number: 29/109,823
Type: Grant
Filed: Aug 25, 1999
Date of Patent: Feb 27, 2001
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventor: Steve McGugan (Copenhagen)
Primary Examiner: Alan P. Douglas
Assistant Examiner: Reid Hecker
Attorney, Agent or Law Firms: Theodore R. Furman, Jr., Stuart E. Krieger
Application Number: 29/109,823
Classifications
Current U.S. Class:
Article For The Introduction, Removal Or Collection Of Fluids (e.g., Infusion, Extraction, Irrigation, Etc.) (3) (D24/108)
International Classification: 2401;
International Classification: 2401;